CLINICAL_TRIALS
trial_result
· 2016-03-01
Clinical Trial Update: ERP Based Single-dose Predictions of Stimulants [Phase 2]
Summary
Phase 2 ERP-based study evaluating single-dose predictions of stimulants for ADHD has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Ostfold Hospital Trust | Conditions: Attention Deficit Hyperactivity Disorder | Phase 2 | Status: COMPLETED